- Test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of COVID-19 - LumiraDx's microfluidic technology and innovative Point of Care (POC ...
The MarketWatch News Department was not involved in the creation of this content. InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today ...
PASADENA, CA, USA, April 4, 2024 /EINPresswire.com/ -- OSANG Healthcare, a leading healthcare diagnostics company since 1996, has announced its Emergency Use ...
CHICAGO--(BUSINESS WIRE)--BioGX, a global provider of easy molecular diagnostic solutions, announced the launch of a point-of-care (POC) CE-Marked, three gene multiplex COVID-19 test on its pixl ...
Toronto, Ontario--(Newsfile Corp. - June 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
(RTTNews) - LumiraDx (LMDX), a diagnostics company said on Thursday that its latest SARS-CoV-2 & Flu A/B Antigen Test has bagged CE Marking, the European Union's mandatory conformity marking system to ...
In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers summarized data self-reported by users ...
InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback